As of Aug 18
| -1.59 / -1.57%|
The 8 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 160.00, with a high estimate of 208.00 and a low estimate of 61.00. The median estimate represents a +60.13% increase from the last price of 99.92.
The current consensus among 8 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.